ANL
ANALYST COVERAGE1 analysts
BUY
+67.4%upside to target
Buy
1100%
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Key MetricsTTM
Market Cap$638.55M
Revenue TTM$6.49M
Net Income TTM-$54.06M
Free Cash Flow-$66.94M
Gross Margin100.0%
Operating Margin-714.0%
Net Margin-710.6%
Return on Equity-414.0%
Return on Assets-103.2%
Debt / Equity-3.17
Current Ratio0.65
EPS TTM$-3.33
PRICE
Prev Close
11.56
Open
11.53
Day Range11.53 – 12.18
11.53
12.18
52W Range0.88 – 17.25
0.88
17.25
68% of range
VOLUME & SIZE
Avg Volume
377.0K
FUNDAMENTALS
P/E Ratio
-10.8x
Not profitable
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
54
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20

ANL News

About

No description available.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Xiaofeng YeChief Financial Officer
Ngai Chiu TsePresident & Head of Research & Development
Kaiyang TangPresident
Nanhai HeHead of Discovery
Zhiyong YuVice President of Operations
Chen YangHead of HR & Administration & Government Affairs
Donghui YangChairman of the Greater China Region
Yang LuCo- Founder, Chief Executive Officer & Chairman